Annual Report for the Financial Year ended on March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanta Industries has submitted its Annual Report for FY ended March 31, 2025, along with the notice for its 12th AGM to be held on September 30, 2025 via video conferencing. Key agenda items include adoption of audited standalone and consolidated financial statements, re-appointment of director Mr. Parikh H.A., and approval of material related party transactions for FY 2025-26 with seven named related parties (including Vipronova Lifescience, Adline Chem Lab, Vitaaglobal Bioscience and Vivanza Biosciences). The company also seeks shareholder approval to appoint M/s. Jitendra Parmar & Associates as Secretarial Auditor for a five-year term (FY 2025-26 to FY 2029-30) and to alter its main object clause to diversify into agro products, solar/renewable energy, drones, EV charging infrastructure, and IT/software businesses. During the year, both the Company Secretary (Ms. Vinita Keshwani resigned 16/05/2025; Mr. Devang Shah appointed 31/07/2025) and Secretarial Auditor changed mid-year.
Routine annual compliance filing, but shareholders should note the proposed diversification into new sectors (drones, solar, IT, EV) via MOA amendment and the material RPTs seeking approval, which require careful review for fairness. Mid-year changes in Company Secretary and Secretarial Auditor may warrant attention, though statutory auditor M/s. GMCA & Co. remains unchanged.